When diagnosed early, skin cancer is easier and less expensive to treat, and its prognosis is more favorable. However, most patients don’t know what to look for, resulting in unnecessary consultations and further pressure on a system under strain from a shortage of dermatologists. This leads to both over and under treatment, with unnecessary costs being tied up in the skin cancer pathway.
SkinVision puts the skin cancer assessment into the hands of patients, before they make a GP appointment, and directs them to the appropriate next step based on the app’s AI recommendation and/or the SkinVision dermatology team.
With nearly 200,000 users in the UK (1.3m users globally), SkinVision is used to perform 1,500 skin checks every day. The app’s algorithm processes user photos through deep neural networks and classifies them based on similar frameworks identified from other skin cancer photos in the database. Users can understand the level of risk for a skin spot instantly.
SkinVision can be used to address the two week wait list, post referral, as well as a part of the follow-up pathway for remote monitoring.